Conference abstract · 25 Jan 2020
Review articlePublished 2015
Cancer Immunotherapy: Targeting Checkpoint Blockade
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Immune system is developed in such a way that it can efficiently recognize, target and eliminate foreign pathogens effectively, but leave the host self-architecture intact. During the developmental process self-reactive high avidity immune effectors are deleted, and several other mechanisms are put in place to ensure that the self-reactive low avidity immune effectors cannot generate harmful autoimmune reactions. T cells are critical immune effectors of a protective antigen specific adaptive immune response. While engagement of the T cell receptor (TCR) critical for the development of antigen specific T cell response, development of effector function in T cells is fine tuned by positive factors, the co-stimulatory factors, and negative factors, the co-inhibitory receptors. While role of co- stimulation was initially considered critical for the generation of an optimum protective immune response, it is well established that the co-inhibitory molecules play equally essential role in this process. Approaches targeting co- inhibitory receptor mediated immune blockade mechanisms have recently been shown to produce remarkable protective responses in cancer patients. We will here take a brief account of the recent advances towards development of immune checkpoint blockade strategies in cancer immunotherapy.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 18 Jul 2018
Cancer immunotherapy, immune checkpoint blockade and predictive biomarkers
Conference abstract · 17 Jul 2017
Novel antibody for cancer immunotherapy: beyond and synergistic with immune checkpoint blockade therapy
Conference abstract · 3 Sep 2018
Immune checkpoint blockade for solid tumours: Opportunities for imaging to contribute to precision medicine
Short communication · 29 Apr 2024
Checkpoint blockade chronicles: Navigating the frontiers of immunotherapy in cancer treatment.
More from this journal
The newest in Advancements in Genetic Engineering.
Commentary · 1 Jul 2026
Genetic Engineering in Enhancing Human Muscle Regeneration for Degenerative Muscle Disorders
Commentary · 1 Jul 2026
Genetic Engineering in Engineering Human Liver Detoxification Pathways for Chronic Toxic Load Disorders
Perspective · 1 Jul 2026
Genetic Engineering in Developing Synthetic Neural Circuits for Cognitive Function Restoration
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAdvancements in Genetic Engineering
- SubjectGenetics & Molecular Biology
- SubjectEngineering
- BylineArticles whose byline prints “Arvind Chhabra”

